Recent approval of swine flu vaccine’s by top pharmaceutical companies GlaxoSmithKline (GSK), Novartis (NVS) and Baxter International (BAX) to help ease influenza pandemic.

Baxter International completed the production of its first commercial batches of CELVAPAN swine flu vaccine in late July and is discussing plans for distribution with national health authorities, subject to obtaining appropriate authorizations. Due to the global scale of the swine flu pandemic, Baxter has partnered with top pharmaceutical companies to enhance their potential product offerings.